“As a CEO, I value both BioVentures Investors' experience in building shareholder value and their background as founders and advisors to emerging companies.”

Peter Vitulli
President & CEO
Sciona

About Sciona

­

Sciona provides health and nutrition information to consumers based on an individual's diet, lifestyle and unique genetic profile. It has established itself as a pioneer in the emerging scientific field of nutrigenetics, the science of personalizing nutrition and lifestyle choices to match one’s genes.

The firm, located in Boulder, Colorado, was founded in 2000 and started working with BioVentures Investors in 2001. Peter Vitulli, President and CEO of Sciona since 2003 noted Peter Feinstein’s involvement, now and in the formative stages of the company. “Peter is by far the most active member of our Board of Directors. His ability and willingness to step in and run Sciona during an interim period speaks volumes about the extraordinary contribution he has made to Sciona.”

For more information, go to www.sciona.com, and to Sciona’s product site www.mycellf.com.

­
Feature_vitulli_lg

­Peter Vitulli ­­
President & CEO
Sciona

SUCCESS STORIES

» Cylene Pharmaceuticals

» Sciona

» Spirus Medical

» Verax Biomedical